- Home
- LVS vs GEHC Comparison
LVS vs GEHC Comparison
Compare LVS & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVS
- GEHC
- Stock Information
- Founded
- LVS 1988
- GEHC 1892
- Country
- LVS United States
- GEHC United States
- Employees
- LVS N/A
- GEHC N/A
- Industry
- LVS Hotels/Resorts
- GEHC Computer Software: Prepackaged Software
- Sector
- LVS Consumer Discretionary
- GEHC Technology
- Exchange
- LVS Nasdaq
- GEHC Nasdaq
- Market Cap
- LVS 36.2B
- GEHC 32.9B
- IPO Year
- LVS 2004
- GEHC N/A
- Fundamental
- Price
- LVS $57.64
- GEHC $73.73
- Analyst Decision
- LVS Buy
- GEHC Strong Buy
- Analyst Count
- LVS 13
- GEHC 10
- Target Price
- LVS $59.23
- GEHC $89.10
- AVG Volume (30 Days)
- LVS 3.8M
- GEHC 3.0M
- Earning Date
- LVS 10-22-2025
- GEHC 10-29-2025
- Dividend Yield
- LVS 1.74%
- GEHC 0.18%
- EPS Growth
- LVS N/A
- GEHC 41.40
- EPS
- LVS 1.97
- GEHC 4.88
- Revenue
- LVS $11,615,000,000.00
- GEHC $19,967,000,000.00
- Revenue This Year
- LVS $9.11
- GEHC $6.09
- Revenue Next Year
- LVS $4.86
- GEHC $4.65
- P/E Ratio
- LVS $29.24
- GEHC $15.11
- Revenue Growth
- LVS 1.62
- GEHC 2.31
- 52 Week Low
- LVS $30.18
- GEHC $57.65
- 52 Week High
- LVS $58.03
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- LVS 78.32
- GEHC 49.74
- Support Level
- LVS $52.76
- GEHC $72.97
- Resistance Level
- LVS $54.08
- GEHC $74.50
- Average True Range (ATR)
- LVS 1.00
- GEHC 1.24
- MACD
- LVS 0.20
- GEHC 0.08
- Stochastic Oscillator
- LVS 92.25
- GEHC 36.08
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).